Search results for "Urology & Nephrology"

showing 10 items of 361 documents

Pregnancy After Urinary Diversion at Young Ages-Risks and Outcome.

2016

Objective To assess the urologic and obstetric outcomes during and after pregnancy following urinary diversion (UD) performed during childhood or adolescence. Materials and Methods From our UD database, we identified 25 women who became pregnant between 1981 and 2013. Reasons for UD were neurogenic bladder, exstrophy, trauma, sinus urogenitalis, and interstitial cystitis. Seventeen had continent cutaneous diversion, 4 had continent anal diversion, and 4 had colonic conduit. Results The average age at delivery was 27.8 (18-39) years. Thirty-seven pregnancies occurred; 1 patient decided for an induced abortion. Thirty-two healthy children were born. Five patients had a spontaneous abortion be…

AdultRiskmedicine.medical_specialtyAdolescentUrologymedicine.medical_treatmentUrinary systemUrinary Bladder030232 urology & nephrologyAbortionUrinary Diversion03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyUterine ProlapseCystitismedicineHumansUrinary Bladder NeurogenicChildUrinary TractUpper urinary tractRetrospective StudiesPregnancy030219 obstetrics & reproductive medicineUrinary bladderbusiness.industryCesarean SectionUrinary diversionUrinary Reservoirs ContinentInterstitial cystitisUterine prolapsemedicine.diseaseSurgeryPregnancy Complicationsmedicine.anatomical_structureUrinary Tract InfectionsFemalebusinessUrology
researchProduct

Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis

2016

Summary: Our meta-analysis demonstrates that people with nephrolithiasis have decreased bone mineral density, an increased odds of osteoporosis, and potentially an elevated risk of fractures. Introduction: People with nephrolithiasis might be at risk of reduced bone mineral density (BMD) and fractures, but the data is equivocal. We conducted a meta-analysis to investigate if patients with nephrolithiasis have worse bone health outcomes (BMD), osteoporosis, and fractures versus healthy controls (HCs). Methods: Two investigators searched major databases for articles reporting BMD (expressed as g/cm2 or a T- or Z-score), osteoporosis or fractures in a sample of people with nephrolithiasis, and…

Adultmedicine.medical_specialtyBone mineral density Fractures Kidney stone Nephrolithiasis OsteoporosisEndocrinology Diabetes and MetabolismOsteoporosis030232 urology & nephrology030209 endocrinology & metabolismBone mineral density; Fractures; Kidney stone; Nephrolithiasis; OsteoporosisNephrolithiasisNO03 medical and health sciencesFractures Bone0302 clinical medicineBone DensityRisk FactorsInternal medicinemedicineBone mineral densityHumansKidney stoneFemoral neckBone mineralbusiness.industryHazard ratiomedicine.diseaseConfidence intervalRheumatologymedicine.anatomical_structureMeta-analysisOrthopedic surgeryOsteoporosisbusinessFractures
researchProduct

Evaluation of sexual function in females with exstrophy-epispadias-complex: a survey of the multicenter German CURE-Net

2016

Standardized knowledge about genital function in adult female individuals with exstrophy-epispadias complex (EEC) is scarce. The aim of this study was to investigate sexual function using the standardized Female Sexual Function Index (FSFI), and to assess the influence of bladder and vaginal reconstruction and the presence of incontinence on FSFI results.Sixty-one females (aged ≥18 years) recruited by the German multicenter network for congenital uro-rectal malformations (CURE-Net) were asked to complete the FSFI and a self-designed semi-structured questionnaire assessing comprehensive medical data, gynecological, and psychosocial items. Twenty-one eligible females (34%) returned both quest…

Adultmedicine.medical_specialtyEpispadiasSexual BehaviorUrologymedicine.medical_treatment030232 urology & nephrologyEpispadiasUrinary DiversionRisk AssessmentIntroitusCystectomyYoung Adult03 medical and health sciences0302 clinical medicineGermanySurveys and QuestionnairesBody ImagemedicineHumansRetrospective StudiesGynecology030219 obstetrics & reproductive medicineObstetricsbusiness.industryBladder Exstrophymedicine.diseaseSelf ConceptSexual Dysfunction PhysiologicalSexual intercourseNeck of urinary bladderCross-Sectional StudiesTreatment OutcomeSexual dysfunctionPediatrics Perinatology and Child HealthCohortQuality of LifeUrologic Surgical ProceduresFemalemedicine.symptomSexual functionbusinessFollow-Up StudiesJournal of Pediatric Urology
researchProduct

Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithias…

2019

Bladder stones (BS) constitute 5% of urinary stones. Currently, there is no systematic review of their treatment.To assess the efficacy (primary outcome: stone-free rate [SFR]) and morbidity of BS treatments.This systematic review was conducted in accordance with the European Association of Urology Guidelines Office. Database searches (1970-2019) were screened, abstracted, and assessed for risk of bias for comparative randomised controlled trials (RCTs) and nonrandomised studies (NRSs) with ≥10 patients per group. Quality of evidence (QoE) was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool.A total of 2742 abstracts and 59 full-text article…

Adultmedicine.medical_specialtyPercutaneousUrologymedia_common.quotation_subject030232 urology & nephrologyUrologyContext (language use)law.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawLithotripsyUreteroscopymedicineHumansChildSocieties Medicalmedia_commonUrinary Bladder Calculibusiness.industryConvalescenceGuidelinemedicine.diseaseEurope030220 oncology & carcinogenesisMeta-analysisRelative riskPractice Guidelines as TopicBladder stonesbusinessEuropean Urology
researchProduct

The clinical value of PSA increase during intravesical adjuvant therapy for nonmuscle-invasive bladder cancer.

2016

Introduction Prostatic Specific Antigen (PSA), Bacillus Calmette-Guerin (BCG) increase after intravesical BCG has been reported. The need of prostate biopsy in these patients is object of debate. The aim of our study was to evaluate the effect of intravesical therapy on PSA after transurethral resection (TUR) of nonmuscle-invasive bladder cancer (NMIBC). Materials and methods Patients undergoing intravesical chemotherapy or immunotherapy for NMIBC were entered. PSA was measured before TUR, before the first and after the sixth instillation, 30 and 90 days after the last instillation. Patients with PSA ≥4 ng/ml or palpable prostate nodule were excluded. Results Out of 130 patients, 105 were e…

Adultmedicine.medical_specialtyProstate biopsymedicine.medical_treatment030232 urology & nephrologyUrologyAntineoplastic Agents03 medical and health sciencesProstate cancer0302 clinical medicineAdjuvants ImmunologicBiopsyIntravesical instillation Prostate cancer PSAmedicineAdjuvant therapyCombined Modality TherapyHumansNeoplasm InvasivenessAgedAged 80 and overChemotherapyBladder cancermedicine.diagnostic_testbusiness.industryGeneral MedicineImmunotherapyMiddle AgedProstate-Specific Antigenmedicine.diseaseCombined Modality TherapyAdministration IntravesicalUrinary Bladder Neoplasms030220 oncology & carcinogenesisBCG VaccinebusinessUrologia
researchProduct

Sexual Function and Fertility of Women with Classic Bladder Exstrophy and Continent Urinary Diversion

2015

We evaluated the outcome in female patients with classic bladder exstrophy and continent urinary diversion for sexual function and fertility.We reviewed the medical records of female exstrophy patients who underwent continent urinary diversion in our department between 1969 and 2014. Patients were invited for followup examination and asked to complete questionnaires relating to sexual function, social integration and maternity.Of 38 eligible patients 29 (response rate 76%) with a followup of 22.3 years were included in study. Primary continent urinary diversion was done in 62% of patients and 38% underwent secondary continent urinary diversion after failed reconstruction of the exstrophic b…

Adultmedicine.medical_specialtyUrologymedicine.medical_treatmentmedia_common.quotation_subject030232 urology & nephrologyFertilityHuman sexualityUrinary DiversionPelvic Organ Prolapse03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsmedicineHumansRetrospective Studiesmedia_common030219 obstetrics & reproductive medicinebusiness.industryIncidenceGeneral surgeryBladder ExstrophyUrinary Reservoirs ContinentUrinary diversionRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryBladder exstrophySexual Dysfunction PhysiologicalTreatment OutcomeSexual dysfunctionFemalemedicine.symptomSexual functionbusinessInfertility Femalehuman activitiesContinent Urinary DiversionFollow-Up StudiesJournal of Urology
researchProduct

Mitomycin C from birth to adulthood.

2016

Mitomycin C (MMC) intravesical therapy for “superficial” papillary bladder tumors was firstly introduced in the early seventies with promising results. In the following years, several pharmacokinetic studies investigated its mechanism of action to optimize the intravesical administration. Numerous studies confirmed thereafter both the ablative and the prophylactic efficacy and the low toxicity of MMC when intravesically given. In 1984, a complete response rate of 42% in 60 patients not responsive to thiotepa was reported with intravesical MMC at the dose of 40 mg diluted in 40 ml for 8 weeks. In the following decades, many large randomized studies showed the benefit of intravesical prophyla…

Adultmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentMitomycinAntibiotics030232 urology & nephrologyUrologyThioTEPASettore MED/24 - Urologia03 medical and health sciencesYoung Adult0302 clinical medicinePharmacokineticsMedicineHumansYoung adultChildComplete responseAntibiotics Antineoplasticbusiness.industryMedicine (all)digestive oral and skin physiologyMitomycin CGeneral MedicineRegimenUrinary Bladder Neoplasms030220 oncology & carcinogenesisUrinary Bladder NeoplasmbusinessAdjuvantHumanmedicine.drugUrologia
researchProduct

Evaluating hazardous waste generation in for-profit outpatient haemodialysis centres

2015

SUMMARYBackground “Green” haemodialysis management to reduce the environmental impact of haemodialysis is growing. Objectives Dealing with hazardous waste production could heighten healthcare professionals’ awareness of this problem, and improve their healthcare involvement in environmental sustainability and environmental-friendliness. Design and Measurements A list of for-profit outpatient haemodialysis centres in the Valencian Community (E Spain) was compiled. Data on their hazardous waste production from 2008 to 2012 through the annual waste reports issued by official organisations competent in environmental issues were collected. Results There are 22 for-profit dialysis centres, that m…

Advanced and Specialized Nursingbusiness.industrymedicine.medical_treatment030232 urology & nephrology030204 cardiovascular system & hematologyNatural resource03 medical and health sciences0302 clinical medicineNursingNephrologyHazardous wasteHealth careSustainabilityFor profitmedicineProduction (economics)Operations managementEnvironmental impact assessmentbusinessDialysisJournal of Renal Care
researchProduct

Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases.

2013

While acetylcholine (ACh) and muscarinic receptors in the bladder are mainly known for their role in the regulation of smooth muscle contractility, in other tissues they are involved in tissue remodelling and promote cell growth and proliferation. In the present study we have used primary cultures of human detrusor smooth muscle cells (HDSMCs), in order to investigate the role of muscarinic receptors in HDSMC proliferation. Samples were obtained as discarded tissue from men >65 years undergoing radical cystectomy for bladder cancer and cut in pieces that were either immediately frozen or placed in culture medium for the cell culture establishment. HDSMCs were isolated from samples, propagat…

AtropineMalePyrrolidinesMessenger030232 urology & nephrologyGene ExpressionPhosphatidylinositol 3-Kinases0302 clinical medicineAged Atropine; pharmacology Benzofurans; pharmacology Carbachol; pharmacology Cell Proliferation Cells; Cultured Cholinergic Agonists; pharmacology Gene Expression Humans Male Mitogen-Activated Protein Kinases; metabolism Muscarinic Antagonists; pharmacology Myocytes; Smooth Muscle; metabolism Phosphatidylinositol 3-Kinases; metabolism Piperidines; pharmacology Pirenzepine; analogs /&/ derivatives/pharmacology Proto-Oncogene Proteins c-akt; metabolism Pyrrolidines; pharmacology RNA; Messenger; metabolism Receptors; Muscarinic; physiology Urinary Bladder; cytologyPiperidinesSmooth MuscleReceptorsMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptorCells CulturedCulturedMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2Smooth muscle contractionMuscarinic acetylcholine receptor M1Receptors Muscarinic030220 oncology & carcinogenesisMitogen-Activated Protein KinasesAcetylcholinemedicine.drugmedicine.medical_specialtyCarbacholCellsMyocytes Smooth MuscleUrinary BladderMuscarinic AntagonistsBiologyCholinergic Agonists03 medical and health sciencesInternal medicineMuscarinicmedicineHumansRNA MessengerAgedBenzofuransCell ProliferationPharmacologyMyocytesPirenzepineEndocrinologyphysiologycytologyRNACarbacholanalogs /&/ derivatives/pharmacologymetabolismProto-Oncogene Proteins c-aktPharmacological research
researchProduct

Impact of preoperative risk on metastatic progression and cancer-specific mortality in patients with adverse pathology at radical prostatectomy.

2017

Objective To evaluate the impact of preoperative risk category on metastatic disease and prostate cancer-specific mortality (CSM) in patients with prostate cancer (PCa) with adverse pathology at radical prostatectomy (RP). Patients and Methods The records of 6 943 patients who underwent RP at a European tertiary centre were analysed. Biochemical recurrence (BCR), metastatic disease and CSM were assessed for patients with adverse pathology at RP, and stratified according to preoperative low- vs intermediate-/high-risk PCa groups. Kaplan–Meier, cumulative incidence, Cox regression and competing risk regression analyses were performed. Results In patients with extracapsular extension, the meta…

Biochemical recurrenceMalemedicine.medical_specialtyPathologyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyKaplan-Meier EstimateLower riskCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineRisk FactorsMedicineHumansCumulative incidencePathologicalAgedProstatectomybusiness.industryProportional hazards modelProstatectomyHazard ratioProstatic NeoplasmsMiddle AgedProstate-Specific Antigenmedicine.disease030220 oncology & carcinogenesisMultivariate AnalysisbusinessBJU international
researchProduct